0001104659-21-089420.txt : 20210706
0001104659-21-089420.hdr.sgml : 20210706
20210706161550
ACCESSION NUMBER: 0001104659-21-089420
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210701
FILED AS OF DATE: 20210706
DATE AS OF CHANGE: 20210706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scodari Joseph C
CENTRAL INDEX KEY: 0001319892
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40536
FILM NUMBER: 211074256
MAIL ADDRESS:
STREET 1: JOHNSON & JOHNSON
STREET 2: ONE JOHNSON & JOHNSON PLAZA
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acurx Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001736243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 259 LIBERTY AVENUE
CITY: STATEN ISLAND
STATE: NY
ZIP: 10305
BUSINESS PHONE: 917-533-1469
MAIL ADDRESS:
STREET 1: 259 LIBERTY AVENUE
CITY: STATEN ISLAND
STATE: NY
ZIP: 10305
FORMER COMPANY:
FORMER CONFORMED NAME: Acurx Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20180402
4
1
tm2121302d5_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-07-01
0
0001736243
Acurx Pharmaceuticals, Inc.
ACXP
0001319892
Scodari Joseph C
C/O ACURX PHARMACEUTICALS, INC.,
259 LIBERTY AVENUE
STATEN ISLAND
NY
10305
1
0
0
0
Stock Option
6.18
2021-07-01
4
A
0
50000
0
A
2031-06-30
Common Stock
50000
50000
D
This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. 1/36th of the shares granted shall become vested and exercisable as of each monthly anniversary from July 1, 2021, such that all shares subject to this stock option shall be fully vested and exercisable by July 1, 2024.
/s/ Kostantinos Skordalos, Power of Attorney For: Joseph C. Scodari
2021-07-06